Novartis tests new heart pill in small safety trial
NCT ID NCT07465653
Summary
This early-stage study aims to check the safety and measure how the body processes a new experimental drug called HJB647 for people with chronic heart failure. It will involve about 12 participants who will receive the drug or a placebo for three days while staying in a clinic for close monitoring. The main goal is to see if the drug is well-tolerated and to understand how it moves through the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.